{"id":49991,"date":"2022-10-24T17:02:16","date_gmt":"2022-10-24T15:02:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/"},"modified":"2022-10-24T17:02:16","modified_gmt":"2022-10-24T15:02:16","slug":"north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/","title":{"rendered":"North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5661298\/north-america-single-cell-multiomics-market-2021?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=hx89hd&amp;utm_campaign=1766139+-+North+America+Single+Cell+Multiomics+Market+to+Reach+%246.15+Billion+by+2031+at+a+CAGR+of+17.6%25&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;North America Single Cell Multiomics Market 2021-2031 by Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country: Trend Forecast and Growth Opportunity&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221024005727\/en\/1611511\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221024005727\/en\/1611511\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe North America single cell multiomics market is projected to grow by 17.6% annually in the forecast period and reach $ 6,153.0 million by 2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&amp;D investment, and the significant growth in the pharmaceutical industry especially personalized medication.\n<\/p>\n<p>\n<strong>In-depth qualitative analyses include identification and investigation of the following aspects:<\/strong>\n<\/p>\n<ul>\n<li>\nMarket Structure\n<\/li>\n<li>\nGrowth Drivers\n<\/li>\n<li>\nRestraints and Challenges\n<\/li>\n<li>\nEmerging Product Trends &amp; Market Opportunities\n<\/li>\n<li>\nPorter&#8217;s Five Forces\n<\/li>\n<\/ul>\n<p>\nThe trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country.\n<\/p>\n<p>\n<strong>Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nInstruments\n<\/li>\n<li>\nConsumables\n<\/li>\n<li>\nSoftware\n<\/li>\n<\/ul>\n<p>\n<strong>Based on Omics Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nSingle Cell Genomics (SCG)\n<\/li>\n<li>\nSingle Cell Transcriptomics (SCT)\n<\/li>\n<li>\nSingle Cell Proteomics (SCP)\n<\/li>\n<li>\nSingle Cell Metabolomics (SCM)\n<\/li>\n<\/ul>\n<p>\n<strong>By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nClinical Research\n<\/li>\n<li>\nOncology\n<\/li>\n<li>\nCell Therapy\n<\/li>\n<li>\nImmunology\n<\/li>\n<li>\nNeurology\n<\/li>\n<li>\nCell Biology\n<\/li>\n<li>\nOther Types of Clinical Research\n<\/li>\n<li>\nTranslation Research\n<\/li>\n<li>\nSynthetic Biology\n<\/li>\n<\/ul>\n<p>\n<strong>By Sample Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nHuman Samples\n<\/li>\n<li>\nCancer Tissues\n<\/li>\n<li>\nStem Cells\n<\/li>\n<li>\nImmune Cells\n<\/li>\n<li>\nBrain Cells\n<\/li>\n<li>\nOther Human Samples\n<\/li>\n<li>\nAnimal Samples\n<\/li>\n<li>\nMicrobial Samples\n<\/li>\n<\/ul>\n<p>\n<strong>By Workflow, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nSingle-Cell Isolation and Dispensing\n<\/li>\n<li>\nFluorescence-Activated Cell Sorting (FACS)\n<\/li>\n<li>\nMicrofluidics\n<\/li>\n<li>\nMagnetic-Activated Cell Sorting (MACS)\n<\/li>\n<li>\nRandom Seeding\n<\/li>\n<li>\nManual Cell Picking\n<\/li>\n<li>\nLaser Capture Microdissection\n<\/li>\n<li>\nOther Technologies of Single-Cell Isolation and Dispensing\n<\/li>\n<li>\nSingle-Cell Analysis\n<\/li>\n<li>\nPolymerase Chain Reaction\n<\/li>\n<li>\nNext-Generation Sequencing\n<\/li>\n<li>\nMass Cytometry\n<\/li>\n<li>\nMass Spectrometry\n<\/li>\n<li>\nOther Technologies of Single-Cell Analysis\n<\/li>\n<\/ul>\n<p>\n<strong>By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nResearch and Academic Laboratories\n<\/li>\n<li>\nBiopharmaceutical and Biotech Companies\n<\/li>\n<li>\nContract Research Organizations (CROs)\n<\/li>\n<li>\nOther End Users\n<\/li>\n<\/ul>\n<p>\n<strong>Geographically, the following national\/local markets are fully investigated:<\/strong>\n<\/p>\n<ul>\n<li>\nU.S.\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nMexico\n<\/li>\n<\/ul>\n<p>\nFor each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Omics Type, Workflow and End User over the forecast years are also included.\n<\/p>\n<p>\nThe report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.\n<\/p>\n<p>\n<strong>Selected Key Players:<\/strong>\n<\/p>\n<ul>\n<li>\n10x Genomics, Inc.\n<\/li>\n<li>\n1CellBio, Inc.\n<\/li>\n<li>\nBecton, Dickinson and Company\n<\/li>\n<li>\nBerkeley Lights, Inc.\n<\/li>\n<li>\nBGI Genomics Co., Ltd.\n<\/li>\n<li>\nBio-Rad Laboratories, Inc.\n<\/li>\n<li>\nBio-Techne Corporation\n<\/li>\n<li>\nBioTuring, Inc.\n<\/li>\n<li>\nDanaher Corporation (Cytiva Life Sciences)\n<\/li>\n<li>\nDolomite Bio\n<\/li>\n<li>\nFluidigm Corporation\n<\/li>\n<li>\nFluxion Biosciences\n<\/li>\n<li>\nIllimina, Inc\n<\/li>\n<li>\nMission Bio, Inc.\n<\/li>\n<li>\nNamocell, Inc.\n<\/li>\n<li>\nNanoString Technologies, Inc.\n<\/li>\n<li>\nParse Biosciences, Inc.\n<\/li>\n<li>\nProteona\n<\/li>\n<li>\nQiagen N.V.\n<\/li>\n<li>\nRareCyte, Inc.\n<\/li>\n<li>\nScipio Biosciences SAS\n<\/li>\n<li>\nShilps Sciences\n<\/li>\n<li>\nTakara Bio Inc. (Takara Holdings)\n<\/li>\n<li>\nThermo Fisher Scientific Inc.\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Introduction<\/strong>\n<\/p>\n<p>\n<strong>2 Market Overview and Dynamics<\/strong>\n<\/p>\n<p>\n<strong>3 Segmentation of North America Market by Product Type<\/strong>\n<\/p>\n<p>\n<strong>4 Segmentation of North America Market by Omics Type<\/strong>\n<\/p>\n<p>\n<strong>5 Segmentation of North America Market by Application<\/strong>\n<\/p>\n<p>\n<strong>6 Segmentation of North America Market by Sample Type<\/strong>\n<\/p>\n<p>\n<strong>7 Segmentation of North America Market by Workflow<\/strong>\n<\/p>\n<p>\n<strong>8 Segmentation of North America Market by End User<\/strong>\n<\/p>\n<p>\n<strong>9 North America Market 2021-2031 by Country<\/strong>\n<\/p>\n<p>\n<strong>10 Competitive Landscape<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\n10x Genomics, Inc.\n<\/li>\n<li>\n1CellBio, Inc.\n<\/li>\n<li>\nBecton, Dickinson and Company\n<\/li>\n<li>\nBerkeley Lights, Inc.\n<\/li>\n<li>\nBGI Genomics Co., Ltd.\n<\/li>\n<li>\nBio-Rad Laboratories, Inc.\n<\/li>\n<li>\nBio-Techne Corporation\n<\/li>\n<li>\nBioTuring, Inc.\n<\/li>\n<li>\nDanaher Corporation (Cytiva Life Sciences)\n<\/li>\n<li>\nDolomite Bio\n<\/li>\n<li>\nFluidigm Corporation\n<\/li>\n<li>\nFluxion Biosciences\n<\/li>\n<li>\nIllimina, Inc\n<\/li>\n<li>\nMission Bio, Inc.\n<\/li>\n<li>\nNamocell, Inc.\n<\/li>\n<li>\nNanoString Technologies, Inc.\n<\/li>\n<li>\nParse Biosciences, Inc.\n<\/li>\n<li>\nProteona\n<\/li>\n<li>\nQiagen N.V.\n<\/li>\n<li>\nRareCyte, Inc.\n<\/li>\n<li>\nScipio Biosciences SAS\n<\/li>\n<li>\nShilps Sciences\n<\/li>\n<li>\nTakara Bio Inc. (Takara Holdings)\n<\/li>\n<li>\nThermo Fisher Scientific Inc.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5661298\/north-america-single-cell-multiomics-market-2021?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=hx89hd&amp;utm_campaign=1766139+-+North+America+Single+Cell+Multiomics+Market+to+Reach+%246.15+Billion+by+2031+at+a+CAGR+of+17.6%25&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/jhcktj<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x70;&#114;&#x65;&#115;&#x73;&#64;&#x72;&#101;&#x73;&#101;&#x61;&#114;&#x63;&#104;&#x61;&#110;&#x64;&#109;&#x61;&#114;&#x6b;&#101;&#x74;&#115;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;r&#x65;s&#x73;&#64;&#x72;&#101;&#x73;&#101;&#x61;&#114;c&#x68;a&#x6e;d&#x6d;&#97;&#x72;&#107;&#x65;&#116;&#x73;&#46;c&#x6f;m<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;North America Single Cell Multiomics Market 2021-2031 by Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The North America single cell multiomics market is projected to grow by 17.6% annually in the forecast period and reach $ &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49991","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;North America Single Cell Multiomics Market 2021-2031 by Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The North America single cell multiomics market is projected to grow by 17.6% annually in the forecast period and reach $ ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-24T15:02:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221024005727\/en\/1611511\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-24T15:02:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/\"},\"wordCount\":781,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005727\\\/en\\\/1611511\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/\",\"name\":\"North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005727\\\/en\\\/1611511\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-24T15:02:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005727\\\/en\\\/1611511\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005727\\\/en\\\/1611511\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;North America Single Cell Multiomics Market 2021-2031 by Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The North America single cell multiomics market is projected to grow by 17.6% annually in the forecast period and reach $ ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-24T15:02:16+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221024005727\/en\/1611511\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% &#8211; ResearchAndMarkets.com","datePublished":"2022-10-24T15:02:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/"},"wordCount":781,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221024005727\/en\/1611511\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/","name":"North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221024005727\/en\/1611511\/21\/logo.jpg","datePublished":"2022-10-24T15:02:16+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221024005727\/en\/1611511\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221024005727\/en\/1611511\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/north-america-single-cell-multiomics-market-to-reach-6-15-billion-by-2031-at-a-cagr-of-17-6-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"North America Single Cell Multiomics Market to Reach $6.15 Billion by 2031 at a CAGR of 17.6% &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49991"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49991\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}